Virtual Reality Use in Assisted Reproductive Technology

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

August 1, 2023

Study Completion Date

August 1, 2023

Conditions
IVF OutcomesStress Levels
Interventions
DEVICE

Virtual reality

Patients randomized to the study group, will be provided with the VR headset and sensors. The VR exposure will take place before the ET procedure, during their routine pre-transfer waiting period, in a private room. The patient will be able to choose between three different calming VR environments (3 scenes: beach sunset, palm tree patio or redwood forest) and will be exposed to the chosen VR environment for a continuous duration of 15-30 minutes. The VR exposure will be passive, and the patient can control her observation inside the environment by herself, simply by moving her head. During this period, at any time and for any reason, the patient can discontinue the use of the VR session simply by self-removing the helmet

Trial Locations (1)

M5G 1N8

Create Fertility Centre, Toronto

All Listed Sponsors
lead

Dr cliff Librach

OTHER

NCT04394962 - Virtual Reality Use in Assisted Reproductive Technology | Biotech Hunter | Biotech Hunter